Kristian Ängeby

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: LAKARTIDNINGEN. 2022;119:22066

[Jaundice in the adult patient].

Kourie M; Ängeby K; Sjöström M; Fagerström N
Article: BMJ OPEN. 2022;12(9):e060679

Stockholm score of lesion detection on computed tomography following mild traumatic brain injury (SELECT-TBI): study protocol for a multicentre, retrospective, observational cohort study.

Fletcher-Sandersjöö A; Tatter C; Yang L; Pontén E; Boman M; Lassarén P; Forsberg S; Grönlund I; Tidehag V; Rubenson-Wahlin R; Strömmer L; Westberg K; Ängeby K; Djärv T; Lundblad O; Bartek J; Thelin EP
Article: TUBERCULOSIS. 2020;123:101959

CD4+ T cell proliferative responses to PPD and CFP-10 associate with recent M. tuberculosis infection.

Borgström EW; Fröberg G; Correia-Neves M; Atterfelt FB; Bellbrant J; Szulkin R; Chryssanthou E; Ängeby K; Tecleab T; Ruhwald M; Andersen P; Källenius G; Bruchfeld J
Article: GENOME MEDICINE. 2020;12(1):27

Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex.

Merker M; Kohl TA; Barilar I; Andres S; Fowler PW; Chryssanthou E; Ängeby K; Jureen P; Moradigaravand D; Parkhill J; Peacock SJ; Schön T; Maurer FP; Walker T; Köser C; Niemann S
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2016;71(2):333-338

Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB.

Niward K; Ängeby K; Chryssanthou E; Paues J; Bruchfeld J; Jureen P; Giske CG; Kahlmeter G; Schön T
Article: JOURNAL OF LARYNGOLOGY AND OTOLOGY. 2015;129(7):644-655

Otomastoiditis caused by non-tuberculous mycobacteria: report of 16 cases, 3 with infection intracranially.

Lundman L; Edvardsson H; Ängeby K
Article: INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY. 2015;4 Suppl 1:80-81

Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.

Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2015;21(2):148.e5-148.e7

Little difference between minimum inhibitory concentrations of Mycobacterium tuberculosis wild-type organisms determined with BACTEC MGIT 960 and Middlebrook 7H10.

Sturegård E; Ängeby KA; Werngren J; Juréen P; Kronvall G; Giske CG; Kahlmeter G; Schön T
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2015;59(6):3630-3632

Meropenem-clavulanic acid has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.

Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2014;58(12):7557-7559

Intra- and extracellular activities of trimethoprim-sulfamethoxazole against susceptible and multidrug-resistant Mycobacterium tuberculosis.

Davies Forsman L; Schön T; Simonsson USH; Bruchfeld J; Larsson M; Juréen P; Sturegård E; Giske CG; Ängeby K
Article: JOURNAL OF MICROBIOLOGICAL METHODS. 2014;106:146-150

A luciferase-based assay for rapid assessment of drug activity against Mycobacterium tuberculosis including monitoring of macrophage viability.

Larsson MC; Lerm M; Ängeby K; Nordvall M; Juréen P; Schön T
Article: BMC RESEARCH NOTES. 2014;7:512

A 24-well plate assay for simultaneous testing of first and second line drugs against Mycobacterium tuberculosis in a high endemic setting.

Wedajo W; Schön T; Bedru A; Kiros T; Hailu E; Mebrahtu T; Yamuah L; Ängeby K; Werngren J; Onyebujoh P; Dagne K; Aseffa A
Article: EUROPEAN RESPIRATORY JOURNAL. 2013;42(6):1604-1613

The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study.

Hoefsloot W; van Ingen J; Andrejak C; Angeby K; Bauriaud R; Bemer P; Beylis N; Boeree MJ; Cacho J; Chihota V; Chimara E; Churchyard G; Cias R; Daza R; Daley CL; Dekhuijzen PNR; Domingo D; Drobniewski F; Esteban J; Fauville-Dufaux M; Folkvardsen DB; Gibbons N; Gómez-Mampaso E; Gonzalez R; Hoffmann H; Hsueh P-R; Indra A; Jagielski T; Jamieson F; Jankovic M; Jong E; Keane J; Koh W-J; Lange B; Leao S; Macedo R; Mannsåker T; Marras TK; Maugein J; Milburn HJ; Mlinkó T; Morcillo N; Morimoto K; Papaventsis D; Palenque E; Paez-Peña M; Piersimoni C; Polanová M; Rastogi N; Richter E; Ruiz-Serrano MJ; Silva A; da Silva MP; Simsek H; van Soolingen D; Szabó N; Thomson R; Tórtola Fernandez T; Tortoli E; Totten SE; Tyrrell G; Vasankari T; Villar M; Walkiewicz R; Winthrop KL; Wagner D; Nontuberculous Mycobacteria Network European Trial
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2013;17(11):1486-1490

Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience.

Hoffner S; Angeby K; Sturegård E; Jönsson B; Johansson A; Sellin M; Werngren J
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2013;68(9):2074-2077

Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact?

Schön T; Juréen P; Chryssanthou E; Giske CG; Kahlmeter G; Hoffner S; Angeby K
Article: INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY. 2012;1(4):177-179

Tentative susceptibility testing breakpoint for the neuroleptic drug thioridazine, a treatment option for multi- and extensively drug resistant tuberculosis.

Ängeby K; Juréen P; Chryssanthou E; Schön T
Article: BULLETIN OF THE WORLD HEALTH ORGANIZATION. 2012;90(9):693-698

Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis.

Ängeby K; Juréen P; Kahlmeter G; Hoffner SE; Schön T
Article: APMIS. 2012;120(5):405-409

The GenoType® MTBDRplus assay for detection of drug resistance in Mycobacterium tuberculosis in Sweden.

Chryssanthou E; Angeby K
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2012;56(3):1253-1257

Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing.

Werngren J; Sturegård E; Juréen P; Ängeby K; Hoffner S; Schön T
Article: PLOS ONE. 2012;7(6):e39891

Resistance to first-line anti-TB drugs is associated with reduced nitric oxide susceptibility in Mycobacterium tuberculosis.

Idh J; Mekonnen M; Abate E; Wedajo W; Werngren J; Ängeby K; Lerm M; Elias D; Sundqvist T; Aseffa A; Stendahl O; Schön T
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2011;15(4):502-509

Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis.

Schön T; Juréen P; Chryssanthou E; Giske CG; Sturegård E; Kahlmeter G; Hoffner S; Angeby KA
Article: PLOS ONE. 2010;5(11):e13839

Antioxidants protect keratinocytes against M. ulcerans mycolactone cytotoxicity.

Grönberg A; Zettergren L; Bergh K; Ståhle M; Heilborn J; Angeby K; Small PL; Akuffo H; Britton S
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2010;65(5):946-952

Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data.

Angeby KA; Jureen P; Giske CG; Chryssanthou E; Sturegård E; Nordvall M; Johansson AG; Werngren J; Kahlmeter G; Hoffner SE; Schön T
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2010;48(5):1853-1858

Wild-type MIC distributions for aminoglycoside and cyclic polypeptide antibiotics used for treatment of Mycobacterium tuberculosis infections.

Juréen P; Angeby K; Sturegård E; Chryssanthou E; Giske CG; Werngren J; Nordvall M; Johansson A; Kahlmeter G; Hoffner S; Schön T
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2009;64(4):786-793

Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.

Schön T; Juréen P; Giske CG; Chryssanthou E; Sturegård E; Werngren J; Kahlmeter G; Hoffner SE; Angeby KA
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2005;43(7):3159-3161

Drug susceptibility testing of Mycobacterium tuberculosis by a nitrate reductase assay applied directly on microscopy-positive sputum samples.

Musa HR; Ambroggi M; Souto A; Angeby KAK
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2002;40(2):553-555

Rapid and inexpensive drug susceptibility testing of Mycobacterium tuberculosis with a nitrate reductase assay.

Angeby KAK; Klintz L; Hoffner SE
Article: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2000;4(7):684-687

Improved sputum microscopy for a more sensitive diagnosis of pulmonary tuberculosis.

Angeby KA; Alvarado-Gálvez C; Pineda-García L; Hoffner SE
Visa fler

Alla övriga publikationer

Letter: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2011;55(9):4492-4493

Wild-type MIC distributions must be considered to set clinically meaningful susceptibility testing breakpoints for all bacterial pathogens, including Mycobacterium tuberculosis.

Angeby K; Giske CG; Juréen P; Schön T; Pasipanodya JG; Gumbo T
Review: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2008;62(1):56-64

The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.

Martin A; Panaiotov S; Portaels F; Hoffner S; Palomino JC; Angeby K
Letter: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2005;9(6):700-701

Will the bleach method keep its promise in sputum smear microscopy? : Reply

Ängeby K; Hoffner SE; Diwan VK
Review: INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2004;8(7):806-815

Should the 'bleach microscopy method' be recommended for improved case detection of tuberculosis? Literature review and key person analysis.

Angeby KAK; Hoffner SE; Diwan VK
Published conference paper: CLINICAL MICROBIOLOGY AND INFECTION. 2003;9(11):1148-1152

Evaluation of the BacT/ALERT 3D system for recovery and drug susceptibility testing of Mycobacterium tuberculosis.

Angeby KAK; Werngren J; Toro JC; Hedström G; Petrini B; Hoffner SE

Anställningar

Lektor/Specialistläkare, Klinisk forskning och utbildning, Södersjukhuset, Karolinska Institutet, 2021-

Examina och utbildning

Docent, Akutsjukvård, Karolinska Institutet, 2021
MEDICINE DOKTORSEXAMEN, Institutionen för global folkhälsa, Karolinska Institutet, 2004
Läkarexamen, Karolinska Institutet, 1997

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI